Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced preliminary, unaudited product revenue for its fourth fiscal quarter and full fiscal year ended
NeuroOne said preliminary fiscal Q4 product revenue grew 38.4% and that it secured a record $4.5 million purchase order.
Preliminary Fiscal Q4 2026 Product Revenue of $3.8 MillionPreliminary Full-Year Product Revenue Up 15.6% to $10.5 Million, at the Top of Guidance RangeEDEN PRAIRIE, Minn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation NASDAQ:NMTC (“NeuroOne” or the “Company”), a medica…